Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 4 | Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine

Fig. 4

From: Prothrombin complex concentrate for reversal of oral anticoagulants in patients with oral anticoagulation-related critical bleeding: a systematic review of randomised clinical trials

Fig. 4

Exploratory outcomes. Forest-plot displaying the results from meta-analyses of exploratory outcomes. Fixed and random effects estimates displayed. Full definition and timing of outcome assessments in each trial can be found in additional file 6. RR—relative risk, CI—confidence intervals, PCC—prothrombin complex concentrate. * Steiner et al. measured INR-levels 3 h after start of infusion and Sarode et al. measured INR-levels 0.5 h after end of infusion

Back to article page